Skip to content

Nurse-scientist Kimberly Pyke-Grimm draws on her clinical experience when studying how teens, young adults and families make decisions about cancer care.

Nurse-scientist Kimberly Pyke-Grimm draws on her clinical experience when studying how teens, young adults and families make decisions about cancer care.

Published on

Stanford scientists have moved a big step closer toward using engineered immune cells to treat many forms of pediatric cancer.

Stanford scientists have moved a big step closer toward using engineered immune cells to treat many forms of pediatric cancer.

Published on

In this excerpt originally in Months to Years, Michelle Mindlin reflects on how she found courage as she faced cancer repeatedly.

In this excerpt originally in Months to Years, Michelle Mindlin reflects on how she found courage as she faced cancer repeatedly.

Proteins that guide transcription factors from the nuclear membrane to the DNA cause drug-resistant skin cancers and are new targets for drug development.

Proteins that guide transcription factors from the nuclear membrane to the DNA cause drug-resistant skin cancers and are new targets for drug development.

Published on

A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.

A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.

A Stanford-designed computer algorithm helps doctors predict the lifespan of patients with metastatic cancer by looking for clues in their own exam notes.

A Stanford-designed computer algorithm helps doctors predict the lifespan of patients with metastatic cancer by looking for clues in their own exam notes.

Published on

In a new study, a team of researchers has examined the relationship between protein binding to DNA and the development of cancer.

In a new study, a team of researchers has examined the relationship between protein binding to DNA and the development of cancer.

Cancerous tumors cause disease in two ways: they grow and spread. But a new immune therapy approach may be able to target both problems simultaneously.

Cancerous tumors cause disease in two ways: they grow and spread. But a new immune therapy approach may be able to target both problems simultaneously.

Published on

A better understanding of how nanoparticles move from the bloodstream into a tumor could eventually lead to more effective cancer treatment.

A better understanding of how nanoparticles move from the bloodstream into a tumor could eventually lead to more effective cancer treatment.

Published on